Physiological Role
The kidneys continuously filter blood plasma to eliminate metabolic waste, regulate fluid balance, and maintain electrolyte concentrations. This filtration takes place in the glomeruli, tiny vascular structures located in the renal cortex. Each kidney contains roughly one million of them.
The glomerular filtration rate measures the speed at which plasma passes through these glomeruli. A healthy adult filters approximately 180 liters of plasma per day. From this volume, the renal tubules reabsorb nearly all water and useful nutrients, allowing only one to two liters of urine through.
With age, the number of functional nephrons (the kidney's filtration units, each composed of a glomerulus and a tubule) decreases gradually. This loss is estimated at 0.5 to 1 mL/min/1.73 m2 per year after age 40. Combined eGFR quantifies this evolution and distinguishes normal physiological decline from accelerated functional impairment.
Reference Ranges
These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.
Source : NEJM / Inker et al., New Equations to Estimate GFR from Serum Creatinine and Cystatin C (2021)
Biological Significance
A combined eGFR in the optimal zone indicates that the kidneys are filtering plasma efficiently. Filtration capacity is preserved, metabolic waste is cleared, and internal balance is maintained.
Values in the low zone signal a slowdown in filtration. Common causes include aging, chronic hypertension, diabetes, and certain conditions affecting kidney function. A single value in this zone is not conclusive. The trend across multiple successive measurements is more informative than a one-time result.
Values in the very low zone reflect significant impairment of glomerular filtration. Regular monitoring confirms the trend and helps guide appropriate follow-up.
Combined eGFR reading gains precision when compared with creatinine-only and cystatin C-only eGFR estimates. A gap between these two estimates may reveal bias linked to body composition, particularly in muscular individuals.
Influencing Factors
Age. eGFR naturally declines with aging. After 40, the average loss is 0.5 to 1 mL/min/1.73 m2 per year. This evolution is physiological.
Hydration. Even mild dehydration can temporarily lower eGFR by reducing blood volume reaching the kidneys. Stable hydration before the blood draw ensures a representative result.
Diet. High protein intake transiently increases eGFR by stimulating renal perfusion. A very restrictive diet or prolonged fasting can decrease it.
Blood pressure. Chronic hypertension progressively damages the glomeruli. Maintaining blood pressure within normal ranges is a well-documented lever for kidney preservation.
Body composition. Creatinine is a byproduct of muscle metabolism. Individuals with high muscle mass may display elevated creatinine without kidney impairment. Combined eGFR compensates for this bias through cystatin C.
Physical activity. Intense exercise can transiently elevate creatinine. Cystatin C is not influenced by exertion. Combined eGFR attenuates these fluctuations.
Medications. Certain anti-inflammatory drugs, ACE inhibitors, and diuretics can alter eGFR. Reporting ongoing treatments facilitates interpretation.
In the Singular Formula
Combined eGFR acts as a safety parameter in the Singular formulation engine. The kidneys filter and eliminate most excess micronutrients. Their filtration capacity directly determines dosage tolerance.
When combined eGFR falls in the very low zone, the engine activates a renal precaution protocol. Creatine, Ca-AKG, glucosamine sulfate, iodine, and L-lysine are removed from the formula. Magnesium dosage is capped, as are vitamin C and glycine. This restriction logic aims to preserve residual filtration capacity.
Combined eGFR is an index calculated from creatinine and cystatin C, two markers measured by Singular. This approach distinguishes high muscle mass from genuine filtration impairment. The engine thus avoids unnecessary adjustments for athletic profiles while protecting those with genuinely reduced kidney function.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Inker LA et al. | 2021 | Cohort Study | New England Journal of Medicine | View on PubMed |
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race This study establishes the new CKD-EPI 2021 equations combining creatinine and cystatin C to estimate GFR without a race variable. The combined formula represents the current standard in nephrology. | ||||
| Matsushita K et al. | 2010 | Meta-analysis | The Lancet | View on PubMed |
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Collaborative meta-analysis of over 1.1 million individuals. eGFR below 60 mL/min/1.73 m2 independently predicts all-cause and cardiovascular mortality in the general population. | ||||
| Shlipak MG et al. | 2013 | Cohort Study | New England Journal of Medicine | View on PubMed |
Cystatin C versus creatinine in determining risk based on kidney function Cystatin C-based eGFR better predicts mortality and advanced kidney outcomes than creatinine-based eGFR alone. Combining both markers provides the best risk stratification. | ||||
| Levey AS et al. | 2009 | Cohort Study | Annals of Internal Medicine | View on PubMed |
A new equation to estimate glomerular filtration rate Foundational article introducing the CKD-EPI equation for eGFR estimation. This formula, more accurate than MDRD at higher GFR values, became the international reference. | ||||
| Waheed S et al. | 2013 | Cohort Study | Clinical Journal of the American Society of Nephrology | View on PubMed |
Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes The combined association of creatinine, albuminuria, and cystatin C improves prediction of mortality and kidney events compared to each marker used alone. | ||||
| Tangri N et al. | 2011 | Cohort Study | JAMA | View on PubMed |
A predictive model for progression of chronic kidney disease to kidney failure Development and validation of a predictive model for progression to severe kidney function impairment integrating eGFR, age, sex, and albuminuria. | ||||
| Tonelli M et al. | 2006 | Systematic Review | Journal of the American Society of Nephrology | View on PubMed |
Chronic kidney disease and mortality risk: a systematic review Systematic review confirming that chronic kidney function impairment is an independent risk factor for all-cause and cardiovascular mortality, even at early stages. | ||||